Is Immunosuppressive and Thrombolytic Therapy Really Effective in a Patient With Intracardiac Thrombosis and Pulmonary Artery Aneurysm due to Behçet’s Disease?
In this article, we report an exceptional case, who had been treated unsuccessfully with a combination of anti-inflammatory/immunosuppressive therapy and thrombolytic agents, to discuss the poor prognosis of pulmonary artery aneurysm accompanying intracardiac thrombosis in juvenile BD.
📌 3 Key Takeaways
🎯
Objective & Hypothesis:Behçet’s disease (BD) is a rare, multisystemic, chronic vasculitic disorder with unknown etiology.
📊
Key Findings & Data:Intracardiac thrombus formation and pulmonary artery aneurysm in BD are very rare.
💡
Conclusion & Impact:In this article, we report an exceptional case, who had been treated unsuccessfully with a combination of anti-inflammatory/immunosuppressive therapy and thrombolytic agents, to discuss the poor prognosis of pulmonary artery aneurysm accompanying intracardiac thrombosis in juvenile BD.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters
Özet
Behçet’s disease (BD) is a rare, multisystemic, chronic vasculitic disorder with unknown etiology. Intracardiac thrombus formation and pulmonary artery aneurysm in BD are very rare. The treatment protocol in patients with vascular involvement, particularly those with pulmonary artery aneurysm accompanied by thrombosis, have not been clearly defined. In this article, we report an exceptional case, who had been treated unsuccessfully with a combination of anti-inflammatory/immunosuppressive therapy and thrombolytic agents, to discuss the poor prognosis of pulmonary artery aneurysm accompanying intracardiac thrombosis in juvenile BD.
🔖
Cite This Article
ÇİFTDEMİR, N. A., GÖKALP, S., EREN, T. (2019). Is Immunosuppressive and Thrombolytic Therapy Really Effective in a Patient With Intracardiac Thrombosis and Pulmonary Artery Aneurysm due to Behçet’s Disease?. art, Cilt: 34 - Sayı: 4, 451–456. https://ajindex.com/articles/147379
Criteria for diagnosis of Behçet’s disease. International Study Group for Behçet’s Disease. Lancet 1990;335:1078-80
Koné-Paut I, Shahram F, Darce-Bello M, Cantarini L, Cimaz R, Gattorno M, et al. Consensus classification criteria for paediatric Behçet’s disease from a prospective observational cohort: PEDBD. Ann Rheum Dis 2016;75:958-64
Merashli M, Eid RE, Uthman I. A review of current management of vasculo-Behcet’s. Curr Opin Rheumatol 2018;30:50-6
Geri G, Wechsler B, Thi Huong du L, Isnard R, Piette JC, Amoura Z, et al. Spectrum of cardiac lesions in Behçet disease: a series of 52 patients and review of the literature. Medicine (Baltimore) 2012;91:25-34
Ebrahimifar P, Shahabi J. Right ventricular thrombosis as a manifestation of Behçet’s syndrome. ARYA Atheroscler 2017;13:91-94
Vivante A, Bujanover Y, Jacobson J, Padeh S, Berkun Y. Intracardiac thrombus and pulmonary aneurysms in an adolescent with Behçet disease. Rheumatol Int 2009;29:575-7
Endo LM, Rowe SM, Romp RL, Buckmaster MA, Atkinson TP. Pulmonary aneurysms and intracardiac thrombi due to Behçet’s disease in an AfricanAmerican adolescent with oculocutaneous albinism. Clin Rheumatol 2007;26:1537-9
Topcuoglu OM, Topcuoglu ED, Altay CM, Genc S. Imaging pearls of pediatric Behçet’s disease. Eur J Radiol 2017;94:115-124
Seyahi E, Yazici H. Behçet’s syndrome: pulmonary vascular disease. Curr Opin Rheumatol 2015;27:18- 23
Koné-Paut I. Behçet’s disease in children, an overview. Pediatr Rheumatol Online J 2016;14:10
Lisitsyna T, Alekberova Z, Ovcharov P, Volkov A, Korsakova J, Nasonov E. Left ventricular intracardiac thrombus in a patient with Behçet disease successfully treated with immunosuppressive agents without anticoagulation: a case report and review of the literature. Rheumatol Int 2015;35:1931-5
Aksu T, Tufekcioglu O. Intracardiac thrombus in Behçet’s disease: four new cases and a comprehensive literature review. Rheumatol Int 2015;35:1269-79
Hatemi G, Silman A, Bang D, Bodaghi B, Chamberlain AM, Gul A, et al. EULAR recommendations for the management of Behçet disease. Ann Rheum Dis 2008;67:1656-62
Canpolat U, Yorgun H, Akdo¤an A, Aytemir K. Successful treatment of intracardiac and pulmonary thrombi in Behçet’s disease with oral anticoagulant and immunosuppressive therapy. Acta Medica (Hradec Kralove) 2012;55:186-8
Özcan ÖU, Gürlek A, Yıldız G, Akbulut ‹M, Tutar E, Erol Ç. Management of pulmonary artery aneurysm and intracardiac thr